Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INBS
INBS | US
2.75
USD-0.37
-11.86%
INBS | US
Loading StockChartView...
About INBS
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/04/2026
Close
2.75
Open
2.78
High
2.89
Low
2.56
Intelligent Bio Solutions Inc. a medical technology company developing non-invasive real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system a revolutionizing portable testing through fingerprint sweat analysis which has the potential for broader applications in additional fields; and biosensor platform for biochemistry immunology tumor markers hormones and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
View LessINBS | US
Risk
93.2
Sharpe
-0.50
Luna's Score
40/100
Recommendation
Sell
Luna says (INBS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
123.3%1 month
93.2%3 months
153.3%6 months
227.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.80
Debt to equity
0.10
Debt to assets
0.06
Ent. to EBITDA
-0.91
Ent. to rev.
0.40
PEG
-
Other Fundamentals
EBITDA
-9.31M
MarketCap
11.69M
MarketCap(USD)
11.69M
Div. yield
-
Op. margin
-386.32
Erngs. growth
-
Rev. growth
64.20
Ret. on equity
-171.71
Short ratio
0.06
Short perc.
7.03
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.26
Range1M
1.94
Range3M
22.34
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
12.38
Price X volume
3.10M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.91 | 46.09 | Cheaper |
| Ent. to Revenue | 0.40 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.80 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 153.34 | 64.12 | Riskier |
| Debt to Equity | 0.10 | -145.53 | Expensive |
| Debt to Assets | 0.06 | 0.35 | Cheaper |
| Market Cap | 11.69M | 9.70B | Emerging |
